Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Read more about Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer.
Baseline serum testosterone in men treated with androgen deprivation therapy and radiotherapy for localized prostate cancer. Read more about Baseline serum testosterone in men treated with androgen deprivation therapy and radiotherapy for localized prostate cancer.
Dosimetric evaluation of automatic segmentation for adaptive IMRT for head-and-neck cancer. Read more about Dosimetric evaluation of automatic segmentation for adaptive IMRT for head-and-neck cancer.
American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy. Read more about American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy.
Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321. Read more about Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321.
Radiation dose-volume effects and the penile bulb. Read more about Radiation dose-volume effects and the penile bulb.
Radiation dose-volume effects in the larynx and pharynx. Read more about Radiation dose-volume effects in the larynx and pharynx.
Quantitative ultrasonic evaluation of radiation-induced late tissue toxicity: pilot study of breast cancer radiotherapy. Read more about Quantitative ultrasonic evaluation of radiation-induced late tissue toxicity: pilot study of breast cancer radiotherapy.
Dose gradient near target-normal structure interface for nonisocentric CyberKnife and isocentric intensity-modulated body radiotherapy for prostate cancer. Read more about Dose gradient near target-normal structure interface for nonisocentric CyberKnife and isocentric intensity-modulated body radiotherapy for prostate cancer.
Radiation-associated breast tumors display a distinct gene expression profile. Read more about Radiation-associated breast tumors display a distinct gene expression profile.
